Üçbilek Enver, Yıldırım Abdullah Emre, Ellik Zeynep, Turan İlker, Haktanıyan Büşra, Orucu Berk, Demir Mehmet, Tozlu Mukaddes, Yılmaz Nimet, Balaban Yasmin, Uyanıkoğlu Ahmet, Akarsu Mesut, Yolaçan Ramazan, Sezgin Orhan, Yalçın Kendal, Aladağ Murat, Toka Bilal, Kefeli Ayşe, Örmeci Aslı, Yurçi Alper, Fidan Sami, Gençdal Genco, Avcıoğlu Ufuk, Çekin Ayhan Hilmi, Ebik Berat, Karatay Eylem, Akyıldız Murat, Köksal Aydın Şeref, Özdoğan Osman C, Karasu Zeki, Idilman Ramazan
Department of Gastroenterology, Mersin University Faculty of Medicine, Mersin, Türkiye.
Department of Internal Medicine, İstanbul Arel University Faculty of Medicine, İstanbul, Türkiye.
Turk J Gastroenterol. 2024 Sep 2;35(10):772-777. doi: 10.5152/tjg.2024.23572.
BACKGROUND/AIMS: The aim of our study was to investigate the underlying causes behind the etiology of cirrhosis in Türkiye.
The study was comprised of patients with cirrhosis located in the gastroenterology clinics of 28 centers in Türkiye between January 2000 and June 2021.
The study group consisted of 4953 cirrhotic patients (median age: 62.2 years, male / female: 58% / 42%). Among the patients, 39% of the patients were compensated, and 61% were decompensated. Furthermore, 47.5% had Child-Pugh class A, 38% had ChildPugh class B, and 14.5% had Child-Pugh class C. The most frequent complaints were abdominal bloating (28%). Ascites (54.2%) was the most common manifestation of decompensation. The median Child-Pugh and MELD-Na scores were 7.0 and 10.0, respectively. The most common cause of cirrhosis was chronic viral hepatitis (43%), followed by cryptogenic cirrhosis (CC) (19%), metabolic dysfunction-associated steatotic liver disease (MASLD)-related cirrhosis (13%), and alcohol-related cirrhosis (11%). Among the 950 patients with CC, 416 had metabolic abnormalities. If these 416 CC patients with metabolic abnormalities were categorized as having MASLDrelated cirrhosis, the proportion of MASLD-related cirrhosis increased to 21%. Thirteen percent of the patients were diagnosed with HCC, while 4% had extrahepatic malignancy. Female breast cancer (18%) and colorectal cancer (18%) were the most frequent extrahepatic malignancies.
Viral hepatitis remains the main cause of cirrhosis in Türkiye. However, its prevalence seems to be declining, whereas the prevalence of steatotic liver disease-related cirrhosis is increasing.
背景/目的:我们研究的目的是调查土耳其肝硬化病因背后的潜在原因。
该研究纳入了2000年1月至2021年6月期间在土耳其28个中心的胃肠病诊所就诊的肝硬化患者。
研究组由4953例肝硬化患者组成(中位年龄:62.2岁,男性/女性:58%/42%)。在这些患者中,39%为代偿期患者,61%为失代偿期患者。此外,47.5%的患者为Child-Pugh A级,38%为Child-Pugh B级,14.5%为Child-Pugh C级。最常见的症状是腹胀(28%)。腹水(54.2%)是失代偿最常见的表现。Child-Pugh和MELD-Na评分的中位数分别为7.0和10.0。肝硬化最常见的病因是慢性病毒性肝炎(43%),其次是隐源性肝硬化(CC)(19%)、代谢功能障碍相关脂肪性肝病(MASLD)相关肝硬化(13%)和酒精性肝硬化(11%)。在950例CC患者中,416例有代谢异常。如果将这416例有代谢异常的CC患者归类为MASLD相关肝硬化,那么MASLD相关肝硬化的比例将增至21%。13%的患者被诊断为肝癌,4%有肝外恶性肿瘤。女性乳腺癌(18%)和结直肠癌(18%)是最常见的肝外恶性肿瘤。
病毒性肝炎仍然是土耳其肝硬化的主要病因。然而,其患病率似乎在下降,而脂肪性肝病相关肝硬化的患病率在上升。